Concepedia

Pamela Lockbaum

PL

9

Publications

1.2K

Citations

9

H-Index

1982

Active since

Affiliations

Amgen (United States)(Current)

University of Southern California

University of California, Los Angeles

Pamela Lockbaum is an author at Amgen (United States) specializing in medicine, pharmacotherapy, and radiation oncology.

Top concepts

Publications per year

1982–2008

9

Publications

9

Safety, Pharmacokinetics, and Activity of ABX-EGF, a Fully Human Anti–Epidermal Growth Factor Receptor Monoclonal Antibody in Patients With Metastatic Renal Cell Cancer

Eric K. Rowinsky, Garry Schwartz, Jared Gollob et al. · Journal of Clinical Oncology · 2004 · 323 citations · Full text

Randomized, Dose-Escalation Study of SD/01 Compared With Daily Filgrastim in Patients Receiving Chemotherapy

Eileen Johnston, Jeffrey Crawford, Susan Blackwell et al. · Journal of Clinical Oncology · 2000 · 267 citations

A new form of Filgrastim with sustained duration in vivo and enhanced ability to mobilize PBPC in both mice and humans

Graham Molineux, Olaf Kinstler, Bob Briddell et al. · Experimental Hematology · 1999 · 239 citations

, , +10

Pharmacokinetic/Pharmacodynamic Modeling of Pegfilgrastim in Healthy Subjects

Lorin Roskos, Peggy Lum, Pamela Lockbaum et al. · The Journal of Clinical Pharmacology · 2006 · 127 citations

, , +10

Dose and Schedule Study of Panitumumab Monotherapy in Patients with Advanced Solid Malignancies

Louis M. Weiner, Arie S. Belldegrun, Jeffrey Crawford et al. · Clinical Cancer Research · 2008 · 124 citations

Rows per page

1–5 of 9